AAIPharma, Inc. has appointed John M. Hall, Ph.D. to the position of president of European operations. With more than 30 years of international experience in the pharmaceutical, chemical and consulting industries, Dr. Hall possesses a broad range of knowledge in R&D operations management, change management, strategic planning, facility design and construction, marketing and international pharmaceutical product development.

Most recently, he served as senior vice president of corporate development for PharmaBio Development, Inc., a subsidiary of Quintiles Transnational Corp. Prior to that he served Quintiles Ltd. as general manager, responsible for European non-clinical operations and latterly responsible for relationships with the company’s European mid-sized and international Japanese accounts. Additional leadership positions held by Dr. Hall include owner and managing director of Pharmacophore, a pharmaceutical and biotechnology product development management consulting firm, senior director of European pre-clinical development for Searle, and manager of marketing development for Monsanto’s Health Care Division.